Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
Author(s) -
Mark G. Thompson,
Edward Stenehjem,
Shaun J. Grannis,
Sarah W. Ball,
Allison L. Naleway,
Toan C. Ong,
Malini B. DeSilva,
Karthik Natarajan,
Catherine H. Bozio,
Ned Lewis,
Kristin Dascomb,
Brian E. Dixon,
Rebecca Birch,
Stephanie A. Irving,
Suchitra Rao,
Elyse O. Kharbanda,
Jungmi Han,
Sue Reynolds,
Kristin Goddard,
Nancy Grisel,
William F. Fadel,
Matthew E. Levy,
Jill M. Ferdinands,
Bruce Fireman,
Julie Arndorfer,
Nimish R. Valvi,
Elizabeth Rowley,
Palak Patel,
Ousseny Zerbo,
Eric P. Griggs,
Rachael M. Porter,
Maria Demarco,
Lenee Blanton,
Andrea Steffens,
Yan Zhuang,
Natalie Olson,
Michelle A. Barron,
Patricia Shifflett,
Stephanie J. Schrag,
Jennifer R. Verani,
Alicia M. Fry,
Manjusha Gaglani,
Eduardo AzzizBaumgartner,
Nicola P. Klein
Publication year - 2021
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2110362
Subject(s) - covid-19 , ambulatory , medicine , inpatient care , ambulatory care , virology , medical emergency , intensive care medicine , health care , outbreak , economics , economic growth , disease , infectious disease (medical specialty)
There are limited data on the effectiveness of the vaccines against symptomatic coronavirus disease 2019 (Covid-19) currently authorized in the United States with respect to hospitalization, admission to an intensive care unit (ICU), or ambulatory care in an emergency department or urgent care clinic.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom